AU2001243394A1 - Compounds and methods - Google Patents

Compounds and methods

Info

Publication number
AU2001243394A1
AU2001243394A1 AU2001243394A AU4339401A AU2001243394A1 AU 2001243394 A1 AU2001243394 A1 AU 2001243394A1 AU 2001243394 A AU2001243394 A AU 2001243394A AU 4339401 A AU4339401 A AU 4339401A AU 2001243394 A1 AU2001243394 A1 AU 2001243394A1
Authority
AU
Australia
Prior art keywords
compounds
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001243394A
Inventor
William E. Bondinell
Thomas W. Ku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2001243394A1 publication Critical patent/AU2001243394A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
AU2001243394A 2000-03-02 2001-03-02 Compounds and methods Abandoned AU2001243394A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18641800P 2000-03-02 2000-03-02
US60186418 2000-03-02
PCT/US2001/006837 WO2001064213A1 (en) 2000-03-02 2001-03-02 Compounds and methods

Publications (1)

Publication Number Publication Date
AU2001243394A1 true AU2001243394A1 (en) 2001-09-12

Family

ID=22684870

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001243394A Abandoned AU2001243394A1 (en) 2000-03-02 2001-03-02 Compounds and methods

Country Status (2)

Country Link
AU (1) AU2001243394A1 (en)
WO (1) WO2001064213A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0202133D0 (en) * 2002-07-08 2002-07-08 Astrazeneca Ab Novel compounds
SE0302755D0 (en) * 2003-10-17 2003-10-17 Astrazeneca Ab Novel compounds
SE0303090D0 (en) * 2003-11-20 2003-11-20 Astrazeneca Ab Novel compounds
SE0303280D0 (en) * 2003-12-05 2003-12-05 Astrazeneca Ab Novel compounds
CA2548502A1 (en) 2003-12-11 2005-06-30 Yale University Methods and compositions relating to ccr5 antagonist, ifn-.gamma. and il-13 induced inflammation
SE0303541D0 (en) * 2003-12-22 2003-12-22 Astrazeneca Ab New compounds
RU2006132465A (en) * 2004-02-10 2008-03-20 Ф.Хоффманн-Ля Рош Аг (Ch) CCR5 CHEMOKIN RECEPTOR MODULATORS
US7820817B2 (en) 2004-05-28 2010-10-26 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
US7786141B2 (en) 2004-08-19 2010-08-31 Vertex Pharmaceuticals Incorporated Dihydrospiroindene modulators of muscarinic receptors
EP2374455A3 (en) 2004-08-19 2012-03-28 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
RU2007124373A (en) 2004-11-29 2009-01-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) MUSCARINE RECEPTION MODULATORS
US8263605B2 (en) 2006-02-22 2012-09-11 Vertex Pharmaceutical Incorporated Modulators of muscarinic receptors
EP1988892A2 (en) 2006-02-22 2008-11-12 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
US7858790B2 (en) 2006-06-29 2010-12-28 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
AU2007284548A1 (en) 2006-08-15 2008-02-21 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
CN101573121A (en) 2006-08-18 2009-11-04 弗特克斯药品有限公司 Modulators of muscarinic receptors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9519033D0 (en) * 1995-09-18 1995-11-15 Smithkline Beecham Plc Treatment
WO1997017351A1 (en) * 1995-11-08 1997-05-15 Smithkline Beecham Plc Spiro piperidine derivatives as 5mt receptor antagonists
GB9605883D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
WO2001064213A1 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2001262847A1 (en) Language-understanding
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001258349A1 (en) Bisacylguanidine
AU2001279754A1 (en) Indoloquinazolinones
AU2001243394A1 (en) Compounds and methods
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001258924A1 (en) Microsatellite-aflp
AU2002359694A1 (en) Compounds and methods
AUPQ872300A0 (en) Compounds and methods
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001278951A1 (en) Compounds and methods
AU2001281921A1 (en) Bdellosomes
AU2001266176A1 (en) Methods
AU2001246864A1 (en) Hypotensors
AU4432001A (en) Trityl-type compounds and their use
AU2002235277A1 (en) Compounds and methods
AU2002256556A1 (en) Sea-trosy and related methods
AU2001250536A1 (en) Methods